Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Randox Laboratories' KRAS/BRAF/PIK3CA Array

Premium

Randox Laboratories this week launched its KRAS/BRAF/PIK3CA Array. The company said that clinicians can use the chip to select appropriate patients for colorectal cancer patients undergoing anti-EGFR therapy.

The KRAS/BRAF/PIK3CA Array is designed for the qualitative detection of point mutations within the genes KRAS, BRAF and PIK3CA from tissue DNA, Randox said.

The array is compatible for use with a range of genomic DNA samples including; cell lines, formalin-fixed, paraffin-embedded tissue and fresh/frozen tissue.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.